Impact of Lymph Node Ratio on Survival in Papillary Thyroid Cancer

被引:128
作者
Schneider, David F. [1 ]
Chen, Herbert [1 ]
Sippel, Rebecca S. [1 ]
机构
[1] Univ Wisconsin, Dept Surg, Sect Endocrine Surg, Madison, WI 53706 USA
关键词
CENTRAL NECK DISSECTION; THYROGLOBULIN LEVELS; CARCINOMA; METASTASIS; THERAPY;
D O I
10.1245/s10434-012-2802-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In papillary thyroid cancer, the role of lymph node dissection remains controversial, and staging systems consider metastatic lymph nodes as a binary entity. The purpose of this study was to determine a threshold lymph node ratio (LNR) that impacted disease-specific mortality (DSM). We utilized the surveillance, epidemiology, and end results (SEER) database to analyze adult patients who underwent thyroidectomy with lymph node dissection. A LNR (metastatic lymph nodes to total lymph nodes) was calculated after eliminating patients with less than three nodes collected. Kaplan-Meier estimates for DSM were plotted for LNRs and compared by the log rank test. The Cox proportional hazards model was used to evaluate LNR with other known clinical and pathologic determinants of prognosis. A total of 10,955 cases contained data on lymph nodes. Median follow-up time was 25 months (range 0-59 months), and the mean LNR was 0.28 +/- A 0.37. After comparing Kaplan-Meier survival estimates and overall DSM rates, we found that a LNR a parts per thousand yen0.42 best divided those with lymph node metastasis based on DSM (p < 0.01). Those with a LNR a parts per thousand yen0.42 experienced a DSM rate of 1.72 % while those with a LNR < 0.42 had a DSM rate of 0.65 % (p < 0.01). In addition, patients with a LNR a parts per thousand yen0.42 experienced a 77 % higher DSM rate compared to those with metastatic lymph nodes as a whole. When considered with other known determinants of prognosis, we found that LNR was strongly associated with DSM (hazard ratio 4.33, 95 % confidence interval 1.68-11.18, p < 0.01). LNR is a strong determinant of DSM, and a threshold LNR of 0.42 can be used to risk-stratify patients with metastatic lymph nodes.
引用
收藏
页码:1906 / 1911
页数:6
相关论文
共 26 条
  • [1] Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes
    Arturi, F
    Russo, D
    Giuffrida, D
    Ippolito, A
    Perrotti, N
    Vigneri, R
    Filetti, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (05) : 1638 - 1641
  • [2] Beal SH, 2010, AM SURGEON, V76, P28
  • [3] PROGNOSTIC INDEX FOR THYROID-CARCINOMA - STUDY OF THE EORTC-THYROID-CANCER-COOPERATIVE-GROUP
    BYAR, DP
    GREEN, SB
    DOR, P
    WILLIAMS, ED
    COLON, J
    VANGILSE, HA
    MAYER, M
    SYLVESTER, RJ
    VANGLABBEKE, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1979, 15 (08) : 1033 - 1041
  • [4] CADY B, 1988, SURGERY, V104, P947
  • [5] Increasing incidence of thyroid cancer in the United States, 1973-2002
    Davies, L
    Welch, HG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (18): : 2164 - 2167
  • [6] Edge SB, 2010, AJCC CANC STAGING AT
  • [7] Grubbs Elizabeth G, 2007, J Natl Compr Canc Netw, V5, P623
  • [8] HAY ID, 1987, SURGERY, V102, P1088
  • [9] Central Neck Dissection for Papillary Thyroid Cancer
    Hughes, David T.
    Doherty, Gerard M.
    [J]. CANCER CONTROL, 2011, 18 (02) : 83 - 88
  • [10] Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer
    Hughes, David T.
    White, Matthew L.
    Miller, Barbra S.
    Gauger, Paul G.
    Burney, Richard E.
    Doherty, Gerard M.
    [J]. SURGERY, 2010, 148 (06) : 1100 - 1106